Agilent Technologies (A): Leerink's Top Pick in Life Science Tools

Leerink Partners analyst, Dan Leonard, believes Agilent Technologies (NYSE: A) has more top-line independent margin expansion opportunity than others in the mid to large cap Life Science Tools sector. Following recent due diligence, this remains an important part of the analyst's thesis, yet he also increasingly appreciates the portfolio balance and optionality, an important component of the investment story beyond the immediate margin expansion opportunity. Agilent’s stock remains the analyst's top pick in large cap Tools.

No change to Outperform rating or price target of $51.

For an analyst ratings summary and ratings history on Agilent click here. For more ratings news on Agilent click here.

Shares of Agilent closed at $43.11 yesterday.

You May Also Be Interested In

• Agilent Technologies (A) Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
• Evercore ISI Starts Astera Labs (ALAB) at Outperform
• KKR (KKR) PT Raised to $115 at JMP Securities